1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Zhang, Y.
Swietnicki, W.
Zagorski, M.G.
Surewicz, W.K.
Soennichsen, F.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
275
33650
33654
10.1074/jbc.C000483200
10954699
Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases.
2000
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
16169.063
PRION PROTEIN
PRP(90-231)
E200K
1
man
polymer
no
no
GQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEY
SNQNNFVHDCVNITIKQHTVTTTTKGENFTKTDVKMMERVVEQMCITQYERESQAYYQRGSS
GQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEY
SNQNNFVHDCVNITIKQHTVTTTTKGENFTKTDVKMMERVVEQMCITQYERESQAYYQRGSS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
BRAIN
9606
BRAIN
Homo sapiens
562
Escherichia coli
PLASMID
PET3
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2000-09-21
1
1
2007-10-21
1
2
2011-07-13
1
3
2018-03-14
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2000-08-09
REL
The structure was determined using triple-resonance NMR spectroscopy.
structures with the lowest energy
60
1
3D_13C-separated_NOESY
3D_15N-separated_NOESY
0.00001
4.6
1
atm
299
K
simulated annealing
molecular dynamics
11
lowest energy
0.8 mM E200K(90-231)PrP U-15N,13C; 10mM acetate buffer
90% H2O/10% D2O
Brunger
structure solution
CNS
0.9
Nigles
structure solution
ARIA
0.9
Brunger
refinement
CNS
0.9
800
Bruker
DRX
600
Varian
INOVA
n
1
90
A
n
2
91
A
n
3
92
A
n
4
93
A
n
5
94
A
n
6
95
A
n
7
96
A
n
8
97
A
n
9
98
A
n
10
99
A
n
11
100
A
n
12
101
A
n
13
102
A
n
14
103
A
n
15
104
A
n
16
105
A
n
17
106
A
n
18
107
A
n
19
108
A
n
20
109
A
n
21
110
A
n
22
111
A
n
23
112
A
n
24
113
A
n
25
114
A
n
26
115
A
n
27
116
A
n
28
117
A
n
29
118
A
n
30
119
A
n
31
120
A
n
32
121
A
n
33
122
A
n
34
123
A
n
35
124
A
LEU
125
n
36
LEU
125
A
GLY
126
n
37
GLY
126
A
GLY
127
n
38
GLY
127
A
TYR
128
n
39
TYR
128
A
MET
129
n
40
MET
129
A
LEU
130
n
41
LEU
130
A
GLY
131
n
42
GLY
131
A
SER
132
n
43
SER
132
A
ALA
133
n
44
ALA
133
A
MET
134
n
45
MET
134
A
SER
135
n
46
SER
135
A
ARG
136
n
47
ARG
136
A
PRO
137
n
48
PRO
137
A
ILE
138
n
49
ILE
138
A
ILE
139
n
50
ILE
139
A
HIS
140
n
51
HIS
140
A
PHE
141
n
52
PHE
141
A
GLY
142
n
53
GLY
142
A
SER
143
n
54
SER
143
A
ASP
144
n
55
ASP
144
A
TYR
145
n
56
TYR
145
A
GLU
146
n
57
GLU
146
A
ASP
147
n
58
ASP
147
A
ARG
148
n
59
ARG
148
A
TYR
149
n
60
TYR
149
A
TYR
150
n
61
TYR
150
A
ARG
151
n
62
ARG
151
A
GLU
152
n
63
GLU
152
A
ASN
153
n
64
ASN
153
A
MET
154
n
65
MET
154
A
HIS
155
n
66
HIS
155
A
ARG
156
n
67
ARG
156
A
TYR
157
n
68
TYR
157
A
PRO
158
n
69
PRO
158
A
ASN
159
n
70
ASN
159
A
GLN
160
n
71
GLN
160
A
VAL
161
n
72
VAL
161
A
TYR
162
n
73
TYR
162
A
TYR
163
n
74
TYR
163
A
ARG
164
n
75
ARG
164
A
PRO
165
n
76
PRO
165
A
MET
166
n
77
MET
166
A
ASP
167
n
78
ASP
167
A
GLU
168
n
79
GLU
168
A
TYR
169
n
80
TYR
169
A
SER
170
n
81
SER
170
A
ASN
171
n
82
ASN
171
A
GLN
172
n
83
GLN
172
A
ASN
173
n
84
ASN
173
A
ASN
174
n
85
ASN
174
A
PHE
175
n
86
PHE
175
A
VAL
176
n
87
VAL
176
A
HIS
177
n
88
HIS
177
A
ASP
178
n
89
ASP
178
A
CYS
179
n
90
CYS
179
A
VAL
180
n
91
VAL
180
A
ASN
181
n
92
ASN
181
A
ILE
182
n
93
ILE
182
A
THR
183
n
94
THR
183
A
ILE
184
n
95
ILE
184
A
LYS
185
n
96
LYS
185
A
GLN
186
n
97
GLN
186
A
HIS
187
n
98
HIS
187
A
THR
188
n
99
THR
188
A
VAL
189
n
100
VAL
189
A
THR
190
n
101
THR
190
A
THR
191
n
102
THR
191
A
THR
192
n
103
THR
192
A
THR
193
n
104
THR
193
A
LYS
194
n
105
LYS
194
A
GLY
195
n
106
GLY
195
A
GLU
196
n
107
GLU
196
A
ASN
197
n
108
ASN
197
A
PHE
198
n
109
PHE
198
A
THR
199
n
110
THR
199
A
LYS
200
n
111
LYS
200
A
THR
201
n
112
THR
201
A
ASP
202
n
113
ASP
202
A
VAL
203
n
114
VAL
203
A
LYS
204
n
115
LYS
204
A
MET
205
n
116
MET
205
A
MET
206
n
117
MET
206
A
GLU
207
n
118
GLU
207
A
ARG
208
n
119
ARG
208
A
VAL
209
n
120
VAL
209
A
VAL
210
n
121
VAL
210
A
GLU
211
n
122
GLU
211
A
GLN
212
n
123
GLN
212
A
MET
213
n
124
MET
213
A
CYS
214
n
125
CYS
214
A
ILE
215
n
126
ILE
215
A
THR
216
n
127
THR
216
A
GLN
217
n
128
GLN
217
A
TYR
218
n
129
TYR
218
A
GLU
219
n
130
GLU
219
A
ARG
220
n
131
ARG
220
A
GLU
221
n
132
GLU
221
A
SER
222
n
133
SER
222
A
GLN
223
n
134
GLN
223
A
ALA
224
n
135
ALA
224
A
TYR
225
n
136
TYR
225
A
TYR
226
n
137
TYR
226
A
GLN
227
n
138
GLN
227
A
ARG
228
n
139
ARG
228
A
GLY
229
n
140
GLY
229
A
SER
230
n
141
SER
230
A
SER
231
n
142
SER
231
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
GLY
131
A
N
GLY
42
A
O
VAL
161
A
O
VAL
72
1
A
GLY
90
A
GLY
1
1
Y
1
A
GLN
91
A
GLN
2
1
Y
1
A
GLY
92
A
GLY
3
1
Y
1
A
GLY
93
A
GLY
4
1
Y
1
A
GLY
94
A
GLY
5
1
Y
1
A
THR
95
A
THR
6
1
Y
1
A
HIS
96
A
HIS
7
1
Y
1
A
SER
97
A
SER
8
1
Y
1
A
GLN
98
A
GLN
9
1
Y
1
A
TRP
99
A
TRP
10
1
Y
1
A
ASN
100
A
ASN
11
1
Y
1
A
LYS
101
A
LYS
12
1
Y
1
A
PRO
102
A
PRO
13
1
Y
1
A
SER
103
A
SER
14
1
Y
1
A
LYS
104
A
LYS
15
1
Y
1
A
PRO
105
A
PRO
16
1
Y
1
A
LYS
106
A
LYS
17
1
Y
1
A
THR
107
A
THR
18
1
Y
1
A
ASN
108
A
ASN
19
1
Y
1
A
MET
109
A
MET
20
1
Y
1
A
LYS
110
A
LYS
21
1
Y
1
A
HIS
111
A
HIS
22
1
Y
1
A
MET
112
A
MET
23
1
Y
1
A
ALA
113
A
ALA
24
1
Y
1
A
GLY
114
A
GLY
25
1
Y
1
A
ALA
115
A
ALA
26
1
Y
1
A
ALA
116
A
ALA
27
1
Y
1
A
ALA
117
A
ALA
28
1
Y
1
A
ALA
118
A
ALA
29
1
Y
1
A
GLY
119
A
GLY
30
1
Y
1
A
ALA
120
A
ALA
31
1
Y
1
A
VAL
121
A
VAL
32
1
Y
1
A
VAL
122
A
VAL
33
1
Y
1
A
GLY
123
A
GLY
34
1
Y
1
A
GLY
124
A
GLY
35
1
Y
1
A
SER
132
-52.92
172.00
1
A
MET
134
-130.63
-71.03
1
A
PHE
141
-99.71
-93.00
1
A
SER
143
-148.65
-154.30
1
A
ASP
167
-105.55
-157.65
1
A
TYR
169
55.24
74.06
HUMAN PRION PROTEIN (MUTANT E200K)
HUMAN PRION PROTEIN (MUTANT E200K) FRAGMENT 90-231
1
N
N
A
SER
143
A
SER
54
HELX_P
A
MET
154
A
MET
65
1
1
12
A
HIS
155
A
HIS
66
HELX_P
A
TYR
157
A
TYR
68
5
2
3
A
ASN
171
A
ASN
82
HELX_P
A
GLY
195
A
GLY
106
1
3
25
A
THR
199
A
THR
110
HELX_P
A
GLY
229
A
GLY
140
1
4
31
disulf
2.030
A
CYS
179
A
SG
CYS
90
1_555
A
CYS
214
A
SG
CYS
125
1_555
MEMBRANE PROTEIN
three helix, CREUTZFELDT-JAKOB DISEASE, PRION, AGGREGATION, MEMBRANE PROTEIN
PRIO_HUMAN
UNP
1
P04156
90
231
1FKC
90
231
P04156
A
1
1
142
1
GLU
ENGINEERED MUTATION
LYS
200
1FKC
A
P04156
UNP
200
111
2
anti-parallel
A
MET
129
A
MET
40
A
GLY
131
A
GLY
42
A
VAL
161
A
VAL
72
A
TYR
163
A
TYR
74
1
P 1